MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
ATOS — Atossa Therapeutics, Inc. Common Stock
NasdaqAtossa Therapeutics, Inc. Common Stock
$2.27
+0.32(+16.41%)
- O
- 1.96
- H
- 2.30
- L
- 1.96
- V
- 112.71K
⏱️ End-of-day dataAs of Oct 1, 2026
ATOS — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $31.72M | $41.30M | $51.84M | $57.86M | $65.12M | $71.08M |
| Prepaid Assets | $4.49M | $4.08M | $3.56M | $4.35M | $3.25M | $3.14M |
| Restricted Cash | 110,000.00 | 110,000.00 | 110,000.00 | 110,000.00 | 110,000.00 | 110,000.00 |
| Other Current Assets | 352,000.00 | 133,000.00 | 161,000.00 | 200,000.00 | 268,000.00 | 119,000.00 |
| Total Current Assets | $36.67M | $45.62M | $55.68M | $62.52M | $68.74M | $74.46M |
| Other Non Current Assets | $1.27M | $1.99M | $2.33M | $2.00M | $2.00M | $1.99M |
| Total Non Current Assets | $1.27M | $1.99M | $2.33M | $2.00M | $2.00M | $1.99M |
| Total Assets | $37.94M | $47.61M | $58.01M | $64.52M | $70.75M | $76.44M |
| Accounts Payable | $2.57M | $4.29M | $3.54M | $2.01M | $1.17M | 679,000.00 |
| Accrued Expenses | $3.19M | $1.97M | $2.14M | $2.38M | $2.15M | $1.25M |
| Pensions | 559,000.00 | 893,000.00 | 975,000.00 | 876,000.00 | 581,000.00 | $1.53M |
| Other Current Liabilities | $1.14M | $1.10M | $1.57M | $1.56M | $1.53M | $1.51M |
| Total Current Liabilities | $7.46M | $8.26M | $8.22M | $6.82M | $5.42M | $4.97M |
| Total Non Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | $7.46M | $8.26M | $8.22M | $6.82M | $5.42M | $4.97M |
| Common Stock | $1.55M | $1.55M | $23.49M | $23.49M | $23.49M | $23.49M |
| Retained Earnings | $-25.62M | $-24.66M | $-23.56M | $-22.69M | $-21.85M | $-21.18M |
| Total Shareholders Equity | $30.49M | $39.35M | $49.79M | $57.70M | $65.32M | $71.48M |
| Additional Paid In Capital | $28.66M | $28.58M | $26.34M | $26.26M | $26.18M | $26.13M |
| Treasury Stock | $1.48M | $1.48M | $1.48M | $1.48M | $1.48M | $1.48M |
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | 0.00 |